Clinical Trials Logo

Clinical Trial Summary

The Short-Cut trial is a prospective, investigator-initiated, multicenter, randomized controlled trial that is designed to compare the efficacy of cutting balloon angioplasty vs. intravascular lithotripsy prior to drug-eluting stent implantation in patients with moderate to severely calcified coronary arteries.


Clinical Trial Description

The trial will be composed of two cohorts: - Patients treated with up-front rotational atherectomy - Patients in whom atherectomy is not planned Randomization to either cutting balloon angioplasty or intravascular lithotripsy will occur as follows in the 2 cohorts: - After rotational atherectomy is safely completed In the rotational atherectomy arm - After safe and successful wire crossing in patients in whom atherectomy is not planned. The trial is designed to demonstrate non-inferiority between cutting balloon angioplasty and intravascular lithotripsy in each cohort with regards to the primary endpoint of post-procedural stent area as measured by intravascular imaging at the site of maximal calcification. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06089135
Study type Interventional
Source Baim Institute for Clinical Research
Contact Suzanne Baron, MD, MSc
Phone 617) 461-7002
Email Suzanne.Baron@baiminstitute.org
Status Not yet recruiting
Phase Phase 4
Start date December 31, 2023
Completion date November 30, 2024